An increased intake of lutein/zeaxanthin reduced the long-term risk of advanced age-related macular degeneration, according to a large study.The prospective cohort study included 63,443 women and 38,603 men who participated in the Nurses’ Health Study and Health Professionals Follow-up Study between 1984 and 2010. All subjects were older than 50 years and were not diagnosed with AMD, diabetes, cardiovascular disease or cancer at baseline.
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Appoints Gary M. Phillips, MD, MBA, to Board of Directors
SPK-RPE65 resulted in a sustained difference in functional vision and light sensitivity between study subjects and controls, according to additional data from a phase 3 pivotal trial, Spark Therapeutics announced in a press release.SPK-RPE65 is the company’s lead product candidate for the treatment of RPE65-mediated inherited retinal dystrophies.
Clearside Biomedical completed enrollment in a phase 2 clinical trial of CLS-TA using suprachoroidal space drug administration to treat macular edema associated with noninfectious uveitis, according to a press release. The phase 2 Dogwood trial to eval…
In a humdrum, workaday 30-plus-year career, the typical ophthalmologist labors about 60,000 hours, earns about $10 million and passes the reins down to a replacement surgeon. He or she then has about $3 million left in the bank to spend during another …
Three years ago, a team from the University of Pennsylvania announced that they had cured X-linked retinitis pigmentosa, a blinding retinal disease, in dogs.